Innovid Corp. Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS (Schedule of Fair Value of Warrants Liability) (Details)	3 Months Ended
	Mar. 31, 2021 USD ($)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value as of February 16, 2021 (initial measurement)
Change in fair value	1,407,156
Fair value as of March 31, 2021	31,472,230
Private Placement [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value as of February 16, 2021 (initial measurement)	24,812,195
Change in fair value	893,643
Fair value as of March 31, 2021	25,705,838
Public [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value as of February 16, 2021 (initial measurement)	5,252,879
Change in fair value	513,514
Fair value as of March 31, 2021	5,766,392
Warrants Liability [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value as of February 16, 2021 (initial measurement)	30,065,074
Change in fair value	1,407,156
Fair value as of March 31, 2021	$ 31,472,230